Charles Schwab’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15M Buy
1,221,003
+74,082
+6% +$909K ﹤0.01% 1819
2025
Q1
$25.2M Buy
1,146,921
+99,348
+9% +$2.18M ﹤0.01% 1501
2024
Q4
$23.8M Buy
1,047,573
+103,291
+11% +$2.34M ﹤0.01% 1607
2024
Q3
$17.2M Buy
944,282
+125,620
+15% +$2.28M ﹤0.01% 1777
2024
Q2
$23.9M Buy
818,662
+221,078
+37% +$6.44M ﹤0.01% 1560
2024
Q1
$21.2M Buy
597,584
+33,983
+6% +$1.2M ﹤0.01% 1573
2023
Q4
$24.5M Buy
563,601
+17,863
+3% +$778K 0.01% 1465
2023
Q3
$20.8M Sell
545,738
-156,702
-22% -$5.98M 0.01% 1486
2023
Q2
$28.9M Sell
702,440
-88,275
-11% -$3.63M 0.01% 1238
2023
Q1
$45.4M Buy
790,715
+50,747
+7% +$2.91M 0.01% 909
2022
Q4
$41.5M Buy
739,968
+71,125
+11% +$3.99M 0.01% 941
2022
Q3
$28.3M Buy
668,843
+9,777
+1% +$414K 0.01% 1136
2022
Q2
$35.6M Buy
659,066
+138
+0% +$7.46K 0.01% 981
2022
Q1
$42.3M Buy
658,928
+23,751
+4% +$1.53M 0.01% 982
2021
Q4
$42.6M Buy
635,177
+18,554
+3% +$1.24M 0.01% 1015
2021
Q3
$42.2M Buy
616,623
+30,154
+5% +$2.06M 0.01% 994
2021
Q2
$40M Buy
586,469
+19,848
+4% +$1.35M 0.01% 1032
2021
Q1
$39.1M Buy
566,621
+14,317
+3% +$989K 0.01% 990
2020
Q4
$35.9M Sell
552,304
-1,196
-0.2% -$77.6K 0.01% 992
2020
Q3
$26.1M Buy
553,500
+119
+0% +$5.62K 0.01% 1033
2020
Q2
$26M Buy
553,381
+33
+0% +$1.55K 0.01% 992
2020
Q1
$24.7M Buy
553,348
+2,414
+0.4% +$108K 0.01% 871
2019
Q4
$32.1M Buy
550,934
+6,704
+1% +$391K 0.02% 900
2019
Q3
$32.7M Buy
544,230
+54,640
+11% +$3.28M 0.02% 847
2019
Q2
$27.3M Buy
489,590
+13,192
+3% +$737K 0.02% 930
2019
Q1
$26.5M Buy
476,398
+32,598
+7% +$1.82M 0.02% 933
2018
Q4
$20M Buy
443,800
+1,023
+0.2% +$46.1K 0.02% 1003
2018
Q3
$29.2M Buy
442,777
+139,546
+46% +$9.19M 0.02% 884
2018
Q2
$19.5M Sell
303,231
-64,021
-17% -$4.12M 0.01% 1096
2018
Q1
$20.3M Buy
367,252
+43,642
+13% +$2.42M 0.02% 988
2017
Q4
$15.5M Buy
323,610
+29,836
+10% +$1.43M 0.01% 1171
2017
Q3
$14.8M Buy
293,774
+24,218
+9% +$1.22M 0.01% 1135
2017
Q2
$14.7M Buy
269,556
+24,574
+10% +$1.34M 0.01% 1080
2017
Q1
$10.3M Buy
244,982
+19,008
+8% +$801K 0.01% 1293
2016
Q4
$9.69M Buy
225,974
+14,770
+7% +$634K 0.01% 1277
2016
Q3
$8.72M Sell
211,204
-83,886
-28% -$3.46M 0.01% 1265
2016
Q2
$11.8M Sell
295,090
-21,184
-7% -$845K 0.01% 966
2016
Q1
$10.7M Buy
316,274
+7,268
+2% +$245K 0.01% 1008
2015
Q4
$10.5M Sell
309,006
-8,708
-3% -$295K 0.01% 988
2015
Q3
$9.46M Buy
317,714
+56,759
+22% +$1.69M 0.01% 1036
2015
Q2
$7.19M Buy
260,955
+9,387
+4% +$259K 0.01% 1288
2015
Q1
$6.34M Buy
251,568
+14,671
+6% +$370K 0.01% 1342
2014
Q4
$5.25M Buy
236,897
+6,652
+3% +$147K 0.01% 1407
2014
Q3
$4.67M Buy
230,245
+35,161
+18% +$713K 0.01% 1412
2014
Q2
$3.75M Buy
195,084
+12,147
+7% +$234K 0.01% 1604
2014
Q1
$3.44M Buy
182,937
+9,487
+5% +$178K 0.01% 1617
2013
Q4
$3.38M Buy
173,450
+28,357
+20% +$553K 0.01% 1567
2013
Q3
$2.43M Sell
145,093
-7,254
-5% -$122K 0.01% 1730
2013
Q2
$2.29M Buy
+152,347
New +$2.29M 0.01% 1678